Showing results (111-120 of 790) with videos related to

Sort By:
Pageof 79
NPJ Breast Cancer|June 27, 2017
Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivoJason J Zoeller, Roderick T Bronson, Laura M Selfors, et al.
International Journal of Cancer|March 16, 2012
Detection algorithm for the validation of human cell linesNévine Eltonsy, Vivian Gabisi, Xuesong Li, et al.
NPJ Breast Cancer|September 27, 2017
Erratum: Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivoJason J Zoeller, Roderick T Bronson, Laura M Selfors, et al.
Annual Review of Cancer Biology|July 5, 2021
Ex Vivo Analysis of Primary Tumor Specimens for Evaluation of Cancer TherapeuticsCristina E Tognon, Rosalie C Sears, Gordon B Mills, et al.
Molecular and Cellular Biology|March 9, 2002
Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathwayXianjun Fang, Shuangxing Yu, Janos L Tanyi, et al.
BMC Cancer|February 11, 2018
Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitroOzlem Aslan, Mattia Cremona, Clare Morgan, et al.
Molecular Cell|March 25, 2019
Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in CancerTimothy R Baffi, An-Angela N Van, Wei Zhao, et al.
Cancer Research|April 19, 2005
Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitorsHayato Takeuchi, Yasuko Kondo, Keishi Fujiwara, et al.
British Journal of Cancer|November 30, 2019
Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancersMusaffe Tuna, Zhenlin Ju, Kosuke Yoshihara, et al.
Cancer Journal (Sudbury, Mass.)|April 15, 2017
Identifying Abundant Immunotherapy and Other Targets in Solid Tumors: Integrating RNA-seq and Mass Spectrometry Proteomics Data SetsWei Zhao, Matthew Fitzgibbon, Lindsay Bergan, et al.
Pageof 79